EU panel backs AstraZeneca hypertension drug baxdrostat
GlobeAlert Desk · curated from Arab News · Saudi Arabia · Western Europe
BRUSSELS: AstraZeneca said on Friday a European medicines committee had backed its hypertension pill baxdrostat, branded as Baxfendy, for marketing authorization, potentially making it the first drug of its class to reach patients in the European Union. The Committee for Medicinal Products for Human Use, or CHMP, recommended baxdrostat for adults whose hypertension is insufficiently controlled by at least two medicines. If approved, Baxfendy would be the EU’s first and only aldosterone synt
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
What the desk knows about this story
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Single-source so far. Treat details as unconfirmed until more publishers report.
Not flagged as developing.